1820 McCarthy Blvd.
Milpitas , CA 95035
USA
Product Categories:
Embolic Protection Devices, Stents, Stents Bare Metal, Stents Carotid, Stents Drug Eluting, Vascular Access, Vascular Closure Devices
Embolic Protection Devices, Stents, Stents Bare Metal, Stents Carotid, Stents Drug Eluting, Vascular Access, Vascular Closure Devices
Cordis, a Cardinal Health company, is a worldwide leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients.
Related Content
December 7, 2023 β The U.S. Food and Drug Administration (FDA) announced Cordis US Corp is recalling its INFINITI ...
December 07, 2023
October 18, 2022 β Swiss-based medical technology company MedAlliance has announced it has entered into an agreement ...
October 18, 2022
March 12, 2021 β Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...
March 12, 2021
May 15, 2019 β Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio ...
May 15, 2019November 2, 2018 β Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure ...
November 05, 2018
February 19, 2018 β The Detroit Medical Centerβs (DMC) interventional cardiology team at Heart Hospital recently became ...
February 19, 2018
Feature | Vascular Closure Devices| Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomies ...
January 22, 2018
January 2, 2018 β Osborne & Associates Law Firm, P.A., of Boca Raton, Fla., has filed suit in Palm Beach Circuit Court ...
January 02, 2018
December 13, 2017 β Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration ...
December 13, 2017
November 10, 2017 β Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology ...
November 10, 2017